| 000 | 01628 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516134013.0 | ||
| 264 | 0 | _c20130627 | |
| 008 | 201306s 0 0 eng d | ||
| 022 | _a1476-511X | ||
| 024 | 7 |
_a10.1186/1476-511X-12-15 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFeitosa, Alina C R | |
| 245 | 0 | 0 |
_aLipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment. _h[electronic resource] |
| 260 |
_bLipids in health and disease _cFeb 2013 |
||
| 300 |
_a15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 | _aCarbon Radioisotopes |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCholesterol, HDL _xmetabolism |
| 650 | 0 | 4 |
_aCholesterol, LDL _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xcomplications |
| 650 | 0 | 4 | _aDisease Management |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aDyslipidemias _xcomplications |
| 650 | 0 | 4 |
_aFat Emulsions, Intravenous _xadministration & dosage |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xmetabolism |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xpharmacology |
| 650 | 0 | 4 |
_aLipid Metabolism _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aTriglycerides _xmetabolism |
| 700 | 1 | _aFeitosa-Filho, Gilson S | |
| 700 | 1 | _aFreitas, Fatima R | |
| 700 | 1 | _aWajchenberg, Bernardo L | |
| 700 | 1 | _aMaranhão, Raul C | |
| 773 | 0 |
_tLipids in health and disease _gvol. 12 _gp. 15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1476-511X-12-15 _zAvailable from publisher's website |
| 999 |
_c22494188 _d22494188 |
||